ALPHA TRIBE

Cohance Lifesciences LimitedUpdates, 26-10-2025: General Updates

26-10-2025 | 06:04 pm

USFDA flagged issues at the Nacharam FDF unit, classifying it 'Official Action Indicated'. Remediation started. With <2% US revenue and <1% EBITDA from this unit, the company expects no material impact on operations.

No comments yet. Be the first to comment!

All announcements from Cohance Lifesciences Limited